GPT and metabolic dysfunction-associated steatotic liver disease: Moreover, non-alcoholic fatty liver disease (NAFLD), which has recently been proposed as a feature of the metabolic syndrome [35], was also characterized by chronic elevations in liver transaminase levels, including ALT, AST, and GGT [36,37].